the european network of centres for pharmacoepidemiology and
TRANSCRIPT
ENCePP 10 years of collaboration to strengthen the monitoring of benefits and risks of medicines in Europe.
Expertise and collaboration in pharmacovigilance and pharmacoepidemiology in Europe
Methodological guidance
Governance principles
Increased transparency in high quality, multi-centre, independent non-interventional post-authorisation studies (PAS)
ENCePP Guide on Methodological Standards in Pharmacoepidemiology—a single web resource for methodological English language guidance (6th revision published in July 2017).
ENCePP hosts the public European Union electronic Register of Post-Authorisation Studies (EU PAS Register®).
ENCePP Checklist for Study Protocols
Supporting best practice in study designPromoting transparency on study methods
www.encepp.eu
ENCePP Code of Conduct
Promoting transparency and scientific independence throughout the research process
168 Public institutions and research organisations
18 European countries
83Data sources(by type, July 2017)
31authors
424references selected, commented and updated
4%
84%
2%10%
1145PAS registered (By type, July 2017)
Active surveillance
Observational study
Clinical trial
Other
50%of registered studies were requested by a regulator:
Europe
United States
Rest of the World
5000 views on average per month in 2017 (www.encepp.eu)
850 downloads on average per month in 2017 (www.encepp.eu)
The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) is a network coordinated by the European Medicines Agency (EMA).
The members of this network (the ENCePP partners) are public institutions and contract and research organisations (CRO) involved in research in pharmacoepidemiology and pharmacovigilance.
35%
4%5%23%
10%
19%
4%
Disease registry
Spontaneous reporting database
Prescription event monitoring
Claims/administrative databases
Electronic healthcare records
Medicine registry
Other
40%
6%4%
Not requested
50%